Results 51 to 60 of about 2,710 (195)

Removal of a migrated dexamethasone implant (Ozurdex) from the anterior chamber using an intravenous cannula [PDF]

open access: yes, 2021
Ozurdex is a dexamethasone intravitreal implant used for the treatment of macular oedema. A rare but serious complication is the migration of the implant into the anterior chamber (AC) in eyes with absent or incomplete posterior capsules that may lead to
Ku, Jae Yee   +5 more
core   +1 more source

Dexamethasone implant – An update

open access: yesTNOA Journal of Ophthalmic Science and Research, 2020
Uveitic entities may be infectious or noninfectious in etiology. Corticosteroids remain the first-line treatment for noninfectious posterior uveitis.
Richa Pyare, Jyotirmay Biswas
doaj   +1 more source

Dexamethasone intravitreal implant (Ozurdex) in the treatment of pediatric uveitis [PDF]

open access: yesJournal of American Association for Pediatric Ophthalmology and Strabismus, 2013
To report our experience using Ozurdex (Allergan, Irvine, CA), a biodegradable intravitreal implant containing of 0.7 mg of dexamethasone approved for use in adults with noninfectious uveitis in adults, in the treatment of pediatric uveitis.The medical records of consecutive patients with noninfectious posterior uveitis who were unresponsive to ...
Monica L, Bratton   +2 more
openaire   +2 more sources

Association of treated neovascular AMD with disability and mood disorders: A longitudinal nationwide study

open access: yesActa Ophthalmologica, Volume 104, Issue 6, Page e648-e654, September 2026.
Abstract Purpose To describe the associations of treated neovascular AMD with the risk of disability, falls, fractures and mood disorders in a large sample representative of the French population. Methods Analyses were based on 77 582 individuals belonging to the ‘Echantillon Généraliste des Bénéficiaires’, a 1/97 random sample of the French population,
Cécile Delcourt   +6 more
wiley   +1 more source

Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa [PDF]

open access: yes, 2016
Macular edema (ME) in retinitis pigmentosa (RP) often impairs central vision dramatically. A 41-year-old woman diagnosed with RP was referred to our outpatient clinic due to severe visual deterioration in both eyes.
Nurgül Örnek   +5 more
core   +1 more source

Implantable drug delivery system: Frontiers of medicine‐engineering interdisciplinary

open access: yesInterdisciplinary Medicine, Volume 4, Issue 4, July 2026.
This review systematically summarizes the driving mechanisms of implantable on‐demand drug delivery systems (IDDS), including endogenous, exogenous, and closed‐loop strategies. It highlights the pivotal roles of flexible electronics and miniaturization in enhancing the tissue conformity and spatial adaptability.
Yu Zeng   +9 more
wiley   +1 more source

Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone

open access: yesCase Reports in Ophthalmology, 2012
Background: Macular edema (ME) treatment has benefited from the recent intravitreal pharmacotherapy development of an intravitreal implant of dexamethasone (Ozurdex®, Allergan, Irvine, Calif., USA).
Frederic Matonti   +3 more
doaj   +1 more source

Reply to ‘Vitreoretinal surgery for inadvertent intralenticular Ozurdex implant’ [PDF]

open access: yesEye, 2014
Sir, It is with great interest that we read another case of Ozurdex implant malpositioned in the crystalline lens, as reported by Chalioulias and Muqit.1 Although the complication is rare, with increasing use of intravitreal implants, the number of accidental malpositioning in the crystalline lens may also increase.
R, Chhabra, S, Mahmood
openaire   +2 more sources

Current Landscape and Future Perspectives of Diabetic Retinopathy Therapy: Pharmacological Targets, Precision Laser Technology, and Clinical Evidence

open access: yesMedComm, Volume 7, Issue 7, July 2026.
Targeted biological agents targeting VEGF, integrin, dopamine D2 receptor, ROCK, and BCL‐XL have entered the clinical trial phase and deserve particular attention. The treatment paradigm has shifted toward personalized and precision medicine, positioning optimized SML as a promising adjunctive therapy.
Xinying Hu   +7 more
wiley   +1 more source

Smart Polymer‐Based Drug Delivery Systems for Managing Infective Conjunctivitis: Advances and Future Prospects

open access: yesNano Select, Volume 7, Issue 6, June 2026.
The introduction covers the background and significance of conjunctivitis. It continues with a review of etiology, epidemiology, and clinical manifestations. Diagnostic methods are described, followed by discussions on pathophysiology and classification. Current treatment strategies, preventive measures, and therapeutic challenges are analyzed.
Xia Linkang   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy